Impact of Inflammatory Markers and Body Mass Index on TKI Toxicity in Patients With Non-Small Cell Lung Cancer Harboring an EGFR Mutation

被引：0
|
作者：
Runciman, T. [1 ]
Carracedo, C. [1 ]
Motta, R. [1 ]
Aliaga, C. [1 ]
机构：
[1] Clin Aliada, Lima, Peru
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
NLR; BMI; EGFR NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P76.12
引用
收藏
页码：S590 / S591
页数：2
相关论文
共 50 条
  • [31] EGFR Mutation Testing in Non-Small Cell Lung Cancer
    Sriram, Krishna B.
    Francis, Santiyagu M. Savarimuthu
    Tan, Maxine E.
    Bowman, Rayleen V.
    Yang, Ian A.
    Fong, Kwun M.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (04) : 310 - 321
  • [32] Post-Progression Survival after EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Kogure, Yoshihito
    Saka, Hideo
    Oki, Masahide
    Saito, Toshiki I.
    Ahmed, Shimaa Nour Moursi
    Kitagawa, Chiyoe
    Imaizumi, Kazuyoshi
    PLOS ONE, 2015, 10 (08):
  • [33] Serum carcinoembryonic antigen levels predicts the efficacy of EGFR-TKI in non-small cell lung cancer harboring EGFR mutations
    Zhang Yanwei
    Jin Bo
    Lou Yuqing
    Li Rong
    Zhang Xueyan
    Hu Song
    Han Baohui
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (01) : 254 - 258
  • [34] REBIOPSY IN NON-SMALL CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI
    Yamauchi, Hiroyoshi
    Nakayama, Masayuki
    Yamamoto, Shinichi
    Saito, Tatsuya
    Okuyama, Akiko
    Mato, Naoko
    Yamasawa, Hideaki
    Suzuki, Takuji
    Bando, Masashi
    Hagiwara, Koichi
    RESPIROLOGY, 2017, 22 : 242 - 242
  • [35] Neoadjuvant EGFR-TKI therapy in Non-Small cell lung cancer
    Grant, Christopher
    Nagasaka, Misako
    CANCER TREATMENT REVIEWS, 2024, 126
  • [36] Impact of early progression on prognosis for non-small cell lung cancer patients with EGFR mutation.
    Yoshitsugu, Kanako
    Kenmotsu, Hirotsugu
    Omae, Katsuhiro
    Omori, Shota
    Nakashima, Kazuhisa
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Efficacy and Toxicity of Erlotinib and Gefitinib in Moroccan Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutation
    Benchakroun, N.
    Minoungou, N.
    Bouchbika, Z.
    Jouhadi, H.
    Tawfik, N.
    Sahraoui, S.
    Benider, A.
    Acharki, A.
    Lemzah, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S953 - S953
  • [38] The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI
    Thang Thanh Phan
    Toan Trong Ho
    Hue Thi Nguyen
    Hang Thuy Nguyen
    Thu Bich Tran
    Son Truong Nguyen
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2018, 11 : 423 - 430
  • [39] Postoperative management for non-small cell lung cancer harboring EGFR mutations
    Tanaka, Fumihiro
    Yoneda, Kazue
    Takenaka, Masaru
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4556 - 4560
  • [40] Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer
    Takeda, Masayuki
    Okamoto, Isamu
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2015, 26 : 83 - 84
12345